HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C G Ericsson Selected Research

Fibrinogen (Factor I)

3/2000Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C G Ericsson Research Topics

Disease

2Myocardial Infarction
08/2000 - 03/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
03/2000 - 01/2000
1Diabetes Mellitus
08/2000
1Infarction (Infarctions)
03/2000
1Insulin Resistance
03/2000

Drug/Important Bio-Agent (IBA)

1Insulin (Novolin)FDA Link
03/2000
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2000
1Lipoproteins (Lipoprotein)IBA
03/2000
1Fibric Acids (Fibrates)IBA
03/2000
1BezafibrateIBA
03/2000
1Fibrinogen (Factor I)FDA Link
03/2000
1Glucose (Dextrose)FDA LinkGeneric
03/2000
1Insulin-Like Growth Factor Binding ProteinsIBA
03/2000
1Insulin-Like PeptidesIBA
03/2000
1CholesterolIBA
01/2000
1Apolipoprotein C-I (Apolipoprotein C1)IBA
01/2000

Therapy/Procedure

1Thrombolytic Therapy
08/2000